Explore › Condition › Syphilitic coronary artery disease
Condition

Syphilitic coronary artery disease

Also known as: Late quaternary syphilitic coronary artery disease Syphilitic coronary artery disease Syphilitic coronary artery disease (disorder) coronary artery disease; chronic kidney disease; cardiac arrhythmia; dementia; chronic hypertension CAD CKD
3 findings 1 paper 4 related entities View in graph →

Related entities

interventions
History of1
outcomes
Coronary Artery Disease1
populations
Pregnant Women1
studys
PMC72130621

Findings (27)

None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →
None
decline

Women with a history of preeclampsia/eclampsia showed similar magnitude of cardiovascular and renal disease risk as the broader HDP group, with CAD and CKD remaining significant after Bonferroni corre

Effect: decline; HR 1.89; CI: 95% CI 1.07-3.33

Size: HR 1.89 CI: 95% CI 1.07-3.33
PMC7213062
Finding details → · Paper → · Graph →

Papers (1)